Ras and Raf pathways in epidermis development and carcinogenesis

被引:0
|
作者
F Kern
T Niault
M Baccarini
机构
[1] University of Vienna,
[2] Center for Molecular Biology,undefined
[3] Max F. Perutz Laboratories,undefined
[4] Doktor-Bohr-Gasse 9,undefined
[5] Current address: Microbes and Host Barriers Group,undefined
[6] Inserm Avenir U604,undefined
[7] Institut Pasteur,undefined
[8] 25 Rue du Docteur Roux,undefined
[9] 75724 Paris Cedex 15,undefined
[10] France,undefined
来源
British Journal of Cancer | 2011年 / 104卷
关键词
Raf kinases; Ras pathway; epidermal development; carcinogenesis; differentiation therapy;
D O I
暂无
中图分类号
学科分类号
摘要
The epidermis is the outermost layer of the body and protects it from environmental insults. This crucial function is sustained by a continuous process of self-renewal involving the carefully balanced proliferation and differentiation of progenitor cells constantly replacing the mature cells at the surface of the epidermis. Genetic changes in the signalling pathways controlling keratinocyte proliferation and differentiation disrupt this balance and lead to pathological changes including carcinogenesis. This review discusses the role of Ras, an oncogene critically involved in the development of skin neoplasia, and its downstream effector Raf in epidermal homeostasis and tumourigenesis. In particular, we will focus on the recently established role of Raf-1 as the decisive element that, by restraining keratinocyte differentiation, allows the development and maintenance of Ras-driven tumours.
引用
收藏
页码:229 / 234
页数:5
相关论文
共 50 条
  • [21] Raf promotes Ras dimerization
    Packer, Morgan
    Parker, Jillian
    Chung, Jean
    Li, Zhenlu
    Lee, Young
    Cookis, Trinity
    Guterres, Hugo
    Alvarez, Steven
    Hossain, M. D.
    Donnelly, Daniel
    Agar, Jeffrey
    Makowski, Lee
    Buck, Matthias
    Groves, Jay
    PROTEIN SCIENCE, 2021, 30 : 132 - 132
  • [22] RAF restrained and ready for RAS
    Eck, Michael
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2019, 75 : A220 - A220
  • [23] Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant Gliomas
    Lo, H. -W.
    CURRENT CANCER DRUG TARGETS, 2010, 10 (08) : 840 - 848
  • [24] Molecular dynamics simulations of the Ras:Raf and Rap:Raf complexes
    Zeng, J
    Treutlein, HR
    Simonson, T
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 1999, 35 (01) : 89 - 100
  • [25] RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
    Ting Jin
    Hugo Lavoie
    Malha Sahmi
    Maud David
    Christine Hilt
    Amy Hammell
    Marc Therrien
    Nature Communications, 8
  • [26] RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
    Jin, Ting
    Lavoie, Hugo
    Sahmi, Malha
    David, Maud
    Hilt, Christine
    Hammell, Amy
    Therrien, Marc
    NATURE COMMUNICATIONS, 2017, 8
  • [27] Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development
    Eva Chung
    Motonari Kondo
    Immunologic Research, 2011, 49 : 248 - 268
  • [28] Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development
    Chung, Eva
    Kondo, Motonari
    IMMUNOLOGIC RESEARCH, 2011, 49 (1-3) : 248 - 268
  • [29] Ras-Raf-MEK Pathway
    Schellens, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S14 - S15
  • [30] Ras, Raf, and MAP Kinase in Melanoma
    Solus, Jason F.
    Kraft, Stefan
    ADVANCES IN ANATOMIC PATHOLOGY, 2013, 20 (04) : 217 - 226